INTERNATIONAL PATENT: SAMJIN PHARMACEUTICAL CO., LTD., 삼진제약주식회사 FILES APPLICATION FOR "HETEROCYCLIC DERIVATIVES AS MRGPRX2 ANTAGONISTS AND USES THEREOF"

GENEVA, Aug. 11 -- SAMJIN PHARMACEUTICAL CO., LTD. (121 Wausan-roMapo-guSeoul 04054), 삼진제약주식회사 (서울특별시마포구와우산로 121) filed a patent application (PCT/IB2025/050873) for "HETEROCYCLIC DERIVATIVES AS MRGPRX2 ANTAGONISTS AND USES THEREOF" on Jan 27, 2025. With publication no. WO/2025/163462, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NAM, Eunhye (404ho, 2312dong, 19 Gyenam-roWonmi-gu, B...